| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pediatrics | 3 | 2024 | 117 | 0.990 |
Why?
|
| House Calls | 1 | 2019 | 16 | 0.580 |
Why?
|
| Postnatal Care | 1 | 2019 | 18 | 0.570 |
Why?
|
| Critical Illness | 1 | 2019 | 66 | 0.560 |
Why?
|
| Venous Thrombosis | 1 | 2019 | 98 | 0.550 |
Why?
|
| Mothers | 1 | 2019 | 126 | 0.530 |
Why?
|
| Pancreatitis | 2 | 2014 | 36 | 0.520 |
Why?
|
| Depressive Disorder, Major | 1 | 2019 | 127 | 0.510 |
Why?
|
| Child | 12 | 2024 | 2354 | 0.510 |
Why?
|
| Humans | 44 | 2024 | 29202 | 0.480 |
Why?
|
| Industry | 1 | 2015 | 3 | 0.470 |
Why?
|
| State Government | 1 | 2015 | 18 | 0.460 |
Why?
|
| Lobbying | 1 | 2015 | 9 | 0.460 |
Why?
|
| Clostridium Infections | 5 | 2014 | 72 | 0.460 |
Why?
|
| Immunity, Herd | 1 | 2015 | 3 | 0.450 |
Why?
|
| DNA Barcoding, Taxonomic | 1 | 2014 | 2 | 0.430 |
Why?
|
| Biliary Tract Diseases | 1 | 2014 | 6 | 0.430 |
Why?
|
| Hospitalization | 7 | 2014 | 207 | 0.420 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2014 | 19 | 0.420 |
Why?
|
| Tobacco Use | 1 | 2015 | 103 | 0.420 |
Why?
|
| Models, Genetic | 1 | 2014 | 126 | 0.410 |
Why?
|
| Adolescent | 15 | 2023 | 3254 | 0.410 |
Why?
|
| DNA, Mitochondrial | 1 | 2014 | 87 | 0.410 |
Why?
|
| Influenza, Human | 1 | 2015 | 101 | 0.410 |
Why?
|
| Female | 32 | 2022 | 15819 | 0.390 |
Why?
|
| Male | 30 | 2021 | 14120 | 0.390 |
Why?
|
| Infant | 11 | 2021 | 1066 | 0.390 |
Why?
|
| Social Environment | 1 | 2013 | 58 | 0.380 |
Why?
|
| Child, Preschool | 10 | 2021 | 1213 | 0.370 |
Why?
|
| Pediatric Obesity | 1 | 2013 | 79 | 0.360 |
Why?
|
| Tobacco Products | 1 | 2015 | 209 | 0.360 |
Why?
|
| Cardiopulmonary Resuscitation | 2 | 2022 | 28 | 0.320 |
Why?
|
| United States | 11 | 2019 | 2269 | 0.310 |
Why?
|
| Societies | 1 | 2009 | 9 | 0.300 |
Why?
|
| Education, Graduate | 1 | 2009 | 9 | 0.290 |
Why?
|
| Efficiency | 1 | 2009 | 18 | 0.290 |
Why?
|
| Accreditation | 1 | 2009 | 37 | 0.290 |
Why?
|
| Fellowships and Scholarships | 1 | 2009 | 42 | 0.290 |
Why?
|
| Gene Silencing | 2 | 2021 | 65 | 0.280 |
Why?
|
| Young Adult | 13 | 2023 | 2875 | 0.280 |
Why?
|
| Friedreich Ataxia | 2 | 2021 | 50 | 0.270 |
Why?
|
| Neurocysticercosis | 2 | 2018 | 14 | 0.270 |
Why?
|
| Epilepsy | 2 | 2018 | 37 | 0.260 |
Why?
|
| Family Therapy | 1 | 2007 | 13 | 0.260 |
Why?
|
| Epigenesis, Genetic | 2 | 2021 | 150 | 0.260 |
Why?
|
| Professional Competence | 1 | 2007 | 38 | 0.250 |
Why?
|
| Cross-Sectional Studies | 5 | 2019 | 1012 | 0.250 |
Why?
|
| Bayes Theorem | 2 | 2019 | 102 | 0.250 |
Why?
|
| Teaching | 1 | 2007 | 84 | 0.240 |
Why?
|
| Models, Statistical | 2 | 2019 | 128 | 0.240 |
Why?
|
| Risk Factors | 5 | 2022 | 2144 | 0.240 |
Why?
|
| Papio anubis | 2 | 2017 | 48 | 0.230 |
Why?
|
| Clinical Competence | 3 | 2019 | 249 | 0.220 |
Why?
|
| Cynodon | 1 | 2004 | 1 | 0.210 |
Why?
|
| Infant, Newborn | 8 | 2022 | 932 | 0.210 |
Why?
|
| Databases, Factual | 3 | 2014 | 271 | 0.200 |
Why?
|
| Education, Medical, Undergraduate | 2 | 2015 | 65 | 0.200 |
Why?
|
| Analgesics, Opioid | 2 | 2016 | 121 | 0.200 |
Why?
|
| Child, Hospitalized | 2 | 2013 | 6 | 0.200 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2023 | 30 | 0.190 |
Why?
|
| Biomedical Research | 1 | 2024 | 99 | 0.190 |
Why?
|
| Adult | 10 | 2023 | 8125 | 0.180 |
Why?
|
| Infant, Premature | 3 | 2019 | 149 | 0.180 |
Why?
|
| Resuscitation | 1 | 2022 | 59 | 0.170 |
Why?
|
| Fatigue | 1 | 2022 | 66 | 0.170 |
Why?
|
| Tension-Type Headache | 2 | 2018 | 6 | 0.170 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2021 | 83 | 0.160 |
Why?
|
| Smooth Muscle Tumor | 1 | 2020 | 1 | 0.160 |
Why?
|
| Respiration, Artificial | 1 | 2020 | 42 | 0.160 |
Why?
|
| Retrospective Studies | 8 | 2023 | 2659 | 0.160 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2020 | 16 | 0.150 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2020 | 30 | 0.150 |
Why?
|
| Herpesvirus 4, Human | 1 | 2020 | 45 | 0.150 |
Why?
|
| DNA Methylation | 1 | 2021 | 154 | 0.150 |
Why?
|
| Delivery Rooms | 1 | 2019 | 6 | 0.150 |
Why?
|
| Manikins | 2 | 2022 | 8 | 0.150 |
Why?
|
| Heart Arrest | 1 | 2019 | 27 | 0.150 |
Why?
|
| Attitude to Health | 2 | 2017 | 91 | 0.150 |
Why?
|
| Monitoring, Physiologic | 1 | 2019 | 58 | 0.150 |
Why?
|
| Vocal Cord Paralysis | 1 | 2019 | 5 | 0.150 |
Why?
|
| Parenting | 1 | 2019 | 57 | 0.150 |
Why?
|
| Education, Medical, Graduate | 1 | 2019 | 119 | 0.140 |
Why?
|
| Emigrants and Immigrants | 1 | 2019 | 22 | 0.140 |
Why?
|
| Surveys and Questionnaires | 3 | 2019 | 1021 | 0.140 |
Why?
|
| Phenotype | 1 | 2021 | 689 | 0.140 |
Why?
|
| Infant, Extremely Low Birth Weight | 1 | 2018 | 8 | 0.140 |
Why?
|
| Prospective Studies | 5 | 2023 | 1287 | 0.140 |
Why?
|
| Intubation, Intratracheal | 2 | 2019 | 27 | 0.140 |
Why?
|
| Aorta, Thoracic | 1 | 2019 | 55 | 0.140 |
Why?
|
| Vascular Surgical Procedures | 1 | 2019 | 55 | 0.140 |
Why?
|
| Fetal Growth Retardation | 1 | 2018 | 32 | 0.140 |
Why?
|
| Vitamin D | 1 | 2018 | 54 | 0.140 |
Why?
|
| Lower Extremity | 1 | 2019 | 85 | 0.140 |
Why?
|
| Vitamin D Deficiency | 1 | 2018 | 33 | 0.140 |
Why?
|
| Models, Theoretical | 1 | 2019 | 135 | 0.130 |
Why?
|
| Psychotherapy, Brief | 1 | 2017 | 3 | 0.130 |
Why?
|
| Water Pipe Smoking | 1 | 2017 | 8 | 0.130 |
Why?
|
| Hyperventilation | 1 | 2017 | 4 | 0.130 |
Why?
|
| Ape Diseases | 1 | 2017 | 4 | 0.130 |
Why?
|
| Apnea | 1 | 2017 | 13 | 0.130 |
Why?
|
| Electrocardiography | 1 | 2019 | 398 | 0.130 |
Why?
|
| Respiratory Function Tests | 1 | 2017 | 27 | 0.130 |
Why?
|
| Propofol | 1 | 2017 | 10 | 0.130 |
Why?
|
| Anesthetics, Intravenous | 1 | 2017 | 15 | 0.130 |
Why?
|
| International Classification of Diseases | 2 | 2014 | 38 | 0.130 |
Why?
|
| Curriculum | 1 | 2019 | 307 | 0.130 |
Why?
|
| Clinical Clerkship | 2 | 2015 | 20 | 0.130 |
Why?
|
| Public Opinion | 1 | 2016 | 11 | 0.120 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2016 | 10 | 0.120 |
Why?
|
| Nutrition Assessment | 1 | 2016 | 16 | 0.120 |
Why?
|
| Politics | 1 | 2016 | 17 | 0.120 |
Why?
|
| Beverages | 1 | 2016 | 24 | 0.120 |
Why?
|
| Otolaryngology | 1 | 2016 | 12 | 0.120 |
Why?
|
| Outpatients | 1 | 2016 | 44 | 0.120 |
Why?
|
| Risk Assessment | 1 | 2019 | 632 | 0.120 |
Why?
|
| Internship and Residency | 1 | 2019 | 263 | 0.120 |
Why?
|
| Palate | 1 | 2016 | 8 | 0.120 |
Why?
|
| Monocytes | 1 | 2017 | 135 | 0.120 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2016 | 8 | 0.120 |
Why?
|
| Legislation as Topic | 1 | 2015 | 1 | 0.120 |
Why?
|
| Case-Control Studies | 4 | 2022 | 741 | 0.120 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2016 | 30 | 0.120 |
Why?
|
| Government Regulation | 1 | 2015 | 13 | 0.120 |
Why?
|
| African Americans | 2 | 2016 | 353 | 0.120 |
Why?
|
| Infectious Disease Transmission, Professional-to-Patient | 1 | 2015 | 1 | 0.110 |
Why?
|
| Residential Facilities | 1 | 2015 | 4 | 0.110 |
Why?
|
| New Mexico | 1 | 2015 | 13 | 0.110 |
Why?
|
| Pain, Postoperative | 1 | 2016 | 62 | 0.110 |
Why?
|
| Stochastic Processes | 1 | 2015 | 10 | 0.110 |
Why?
|
| Epidemiological Monitoring | 1 | 2015 | 6 | 0.110 |
Why?
|
| Models, Immunological | 1 | 2015 | 22 | 0.110 |
Why?
|
| Child Day Care Centers | 1 | 2015 | 26 | 0.110 |
Why?
|
| Long-Term Care | 1 | 2015 | 32 | 0.110 |
Why?
|
| Pain Management | 1 | 2016 | 66 | 0.110 |
Why?
|
| Disease Outbreaks | 1 | 2015 | 54 | 0.110 |
Why?
|
| Personal Satisfaction | 1 | 2015 | 31 | 0.110 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 478 | 0.110 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2014 | 12 | 0.110 |
Why?
|
| Seasons | 1 | 2015 | 94 | 0.110 |
Why?
|
| Micronutrients | 1 | 2015 | 49 | 0.110 |
Why?
|
| Psychiatry | 1 | 2015 | 27 | 0.110 |
Why?
|
| Linear Models | 1 | 2015 | 204 | 0.110 |
Why?
|
| Logistic Models | 3 | 2023 | 415 | 0.110 |
Why?
|
| Regression Analysis | 4 | 2018 | 211 | 0.110 |
Why?
|
| Cooperative Behavior | 1 | 2015 | 78 | 0.110 |
Why?
|
| Activities of Daily Living | 1 | 2015 | 107 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 1 | 2016 | 344 | 0.110 |
Why?
|
| Health Personnel | 1 | 2015 | 99 | 0.110 |
Why?
|
| Cystic Fibrosis | 1 | 2014 | 34 | 0.100 |
Why?
|
| Educational Measurement | 1 | 2015 | 142 | 0.100 |
Why?
|
| Postoperative Complications | 1 | 2019 | 643 | 0.100 |
Why?
|
| Computational Biology | 1 | 2015 | 156 | 0.100 |
Why?
|
| Language Development | 1 | 2013 | 5 | 0.100 |
Why?
|
| Ventricular Function | 1 | 2013 | 25 | 0.100 |
Why?
|
| Incidence | 4 | 2019 | 580 | 0.100 |
Why?
|
| Gestational Age | 3 | 2022 | 147 | 0.100 |
Why?
|
| Infant, Extremely Premature | 1 | 2013 | 12 | 0.100 |
Why?
|
| Motor Skills | 1 | 2013 | 34 | 0.100 |
Why?
|
| Emergency Service, Hospital | 1 | 2014 | 124 | 0.100 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2014 | 46 | 0.100 |
Why?
|
| Diet | 1 | 2015 | 243 | 0.100 |
Why?
|
| Fentanyl | 1 | 2013 | 35 | 0.100 |
Why?
|
| Environment Design | 1 | 2013 | 14 | 0.100 |
Why?
|
| Television | 1 | 2013 | 20 | 0.100 |
Why?
|
| Infant, Premature, Diseases | 1 | 2013 | 37 | 0.100 |
Why?
|
| Statistics as Topic | 1 | 2013 | 80 | 0.100 |
Why?
|
| Vaccination | 1 | 2015 | 222 | 0.100 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2013 | 3 | 0.100 |
Why?
|
| Health Surveys | 1 | 2013 | 88 | 0.100 |
Why?
|
| Monkey Diseases | 1 | 2013 | 16 | 0.100 |
Why?
|
| Health Care Costs | 1 | 2013 | 51 | 0.100 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2013 | 44 | 0.100 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2013 | 15 | 0.090 |
Why?
|
| Crohn Disease | 1 | 2013 | 32 | 0.090 |
Why?
|
| Colitis, Ulcerative | 1 | 2013 | 31 | 0.090 |
Why?
|
| Cerebral Hemorrhage | 1 | 2013 | 93 | 0.090 |
Why?
|
| Regional Blood Flow | 1 | 2013 | 168 | 0.090 |
Why?
|
| Organ Transplantation | 1 | 2012 | 13 | 0.090 |
Why?
|
| Smoking Cessation | 1 | 2017 | 431 | 0.090 |
Why?
|
| Cerebrovascular Circulation | 1 | 2013 | 227 | 0.090 |
Why?
|
| Sex Factors | 1 | 2013 | 473 | 0.090 |
Why?
|
| Retinopathy of Prematurity | 1 | 2012 | 40 | 0.090 |
Why?
|
| Hospital Mortality | 1 | 2012 | 159 | 0.090 |
Why?
|
| Cognitive Dysfunction | 1 | 2015 | 271 | 0.090 |
Why?
|
| Kidney Failure, Chronic | 1 | 2012 | 70 | 0.080 |
Why?
|
| Age Factors | 1 | 2013 | 740 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2012 | 125 | 0.080 |
Why?
|
| Oxygen | 1 | 2012 | 238 | 0.080 |
Why?
|
| Body Composition | 1 | 2012 | 267 | 0.080 |
Why?
|
| Cognition | 1 | 2013 | 331 | 0.080 |
Why?
|
| Body Mass Index | 1 | 2012 | 416 | 0.080 |
Why?
|
| Middle Aged | 6 | 2020 | 7493 | 0.080 |
Why?
|
| Evaluation Studies as Topic | 1 | 2009 | 44 | 0.070 |
Why?
|
| Periodicals as Topic | 1 | 2009 | 53 | 0.070 |
Why?
|
| Cardiovascular Diseases | 1 | 2012 | 384 | 0.070 |
Why?
|
| India | 2 | 2018 | 150 | 0.070 |
Why?
|
| Social Responsibility | 1 | 2007 | 11 | 0.060 |
Why?
|
| Data Collection | 1 | 2007 | 109 | 0.060 |
Why?
|
| Diagnosis, Differential | 2 | 2018 | 380 | 0.060 |
Why?
|
| Interviews as Topic | 1 | 2007 | 164 | 0.060 |
Why?
|
| Energy Intake | 2 | 2016 | 69 | 0.060 |
Why?
|
| Multivariate Analysis | 2 | 2018 | 303 | 0.050 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2004 | 7 | 0.050 |
Why?
|
| DNA, Plant | 1 | 2004 | 11 | 0.050 |
Why?
|
| Pilot Projects | 2 | 2017 | 467 | 0.050 |
Why?
|
| Prognosis | 2 | 2020 | 817 | 0.050 |
Why?
|
| Genetic Markers | 1 | 2004 | 92 | 0.050 |
Why?
|
| Lung | 2 | 2020 | 389 | 0.050 |
Why?
|
| Polymorphism, Genetic | 1 | 2004 | 166 | 0.050 |
Why?
|
| Aged | 4 | 2015 | 5647 | 0.050 |
Why?
|
| Genetic Variation | 1 | 2004 | 247 | 0.050 |
Why?
|
| Phylogeny | 1 | 2004 | 500 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2022 | 139 | 0.040 |
Why?
|
| Length of Stay | 2 | 2013 | 248 | 0.040 |
Why?
|
| Registries | 1 | 2023 | 399 | 0.040 |
Why?
|
| Tidal Volume | 1 | 2020 | 6 | 0.040 |
Why?
|
| Ventilators, Mechanical | 1 | 2020 | 10 | 0.040 |
Why?
|
| Alleles | 1 | 2021 | 358 | 0.040 |
Why?
|
| Intermittent Positive-Pressure Ventilation | 1 | 2019 | 2 | 0.040 |
Why?
|
| Osteopathic Medicine | 1 | 2019 | 16 | 0.040 |
Why?
|
| Nitric Oxide | 1 | 2020 | 153 | 0.040 |
Why?
|
| Vocal Cords | 1 | 2019 | 4 | 0.040 |
Why?
|
| Radiosurgery | 1 | 2020 | 85 | 0.040 |
Why?
|
| Rhode Island | 1 | 2018 | 2 | 0.040 |
Why?
|
| Swine Diseases | 1 | 2018 | 13 | 0.040 |
Why?
|
| Brain Edema | 1 | 2018 | 21 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2017 | 2442 | 0.040 |
Why?
|
| Survival Rate | 1 | 2019 | 433 | 0.030 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2018 | 72 | 0.030 |
Why?
|
| Animals | 3 | 2018 | 10802 | 0.030 |
Why?
|
| Tobacco, Waterpipe | 1 | 2017 | 7 | 0.030 |
Why?
|
| Health Risk Behaviors | 1 | 2017 | 7 | 0.030 |
Why?
|
| Parents | 1 | 2019 | 142 | 0.030 |
Why?
|
| Pregnancy | 1 | 2022 | 1261 | 0.030 |
Why?
|
| Swine | 1 | 2018 | 238 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2017 | 183 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 526 | 0.030 |
Why?
|
| Nutritive Sweeteners | 1 | 2016 | 1 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 1033 | 0.030 |
Why?
|
| Portion Size | 1 | 2016 | 6 | 0.030 |
Why?
|
| Diet Surveys | 1 | 2016 | 10 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2017 | 233 | 0.030 |
Why?
|
| Insurance Coverage | 1 | 2016 | 31 | 0.030 |
Why?
|
| Insurance, Health | 1 | 2016 | 51 | 0.030 |
Why?
|
| Hydrocodone | 1 | 2016 | 3 | 0.030 |
Why?
|
| Nucleosomes | 1 | 2016 | 18 | 0.030 |
Why?
|
| Morphine | 1 | 2016 | 29 | 0.030 |
Why?
|
| Acetaminophen | 1 | 2016 | 12 | 0.030 |
Why?
|
| Ibuprofen | 1 | 2016 | 18 | 0.030 |
Why?
|
| RNA Stability | 1 | 2016 | 28 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2016 | 51 | 0.030 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2016 | 20 | 0.030 |
Why?
|
| Recommended Dietary Allowances | 1 | 2015 | 6 | 0.030 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2016 | 38 | 0.030 |
Why?
|
| Iron-Binding Proteins | 1 | 2016 | 41 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2016 | 191 | 0.030 |
Why?
|
| Dietary Carbohydrates | 1 | 2015 | 26 | 0.030 |
Why?
|
| Dietary Proteins | 1 | 2015 | 35 | 0.030 |
Why?
|
| Role | 1 | 2015 | 6 | 0.030 |
Why?
|
| Task Performance and Analysis | 1 | 2015 | 43 | 0.030 |
Why?
|
| Early Medical Intervention | 1 | 2014 | 7 | 0.030 |
Why?
|
| Age Distribution | 1 | 2014 | 75 | 0.030 |
Why?
|
| Nutritional Status | 1 | 2015 | 80 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2014 | 32 | 0.030 |
Why?
|
| Infection Control | 1 | 2014 | 33 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 316 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2016 | 406 | 0.030 |
Why?
|
| Learning | 1 | 2015 | 100 | 0.030 |
Why?
|
| Protein Binding | 1 | 2016 | 667 | 0.030 |
Why?
|
| Cell Line | 1 | 2016 | 705 | 0.030 |
Why?
|
| Acute Disease | 1 | 2014 | 157 | 0.030 |
Why?
|
| Echocardiography, Doppler | 1 | 2013 | 21 | 0.030 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2013 | 23 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 794 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 145 | 0.020 |
Why?
|
| Middle Cerebral Artery | 1 | 2013 | 56 | 0.020 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2013 | 60 | 0.020 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2013 | 26 | 0.020 |
Why?
|
| Respiratory Syncytial Virus Vaccines | 1 | 2013 | 9 | 0.020 |
Why?
|
| Virus Replication | 1 | 2013 | 66 | 0.020 |
Why?
|
| Species Specificity | 1 | 2013 | 197 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 2013 | 81 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2012 | 78 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 613 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2013 | 431 | 0.020 |
Why?
|
| Absorptiometry, Photon | 1 | 2012 | 101 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2012 | 46 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2012 | 237 | 0.020 |
Why?
|
| Oklahoma | 1 | 2015 | 1063 | 0.020 |
Why?
|
| Demography | 1 | 2012 | 94 | 0.020 |
Why?
|
| Indians, North American | 1 | 2016 | 548 | 0.020 |
Why?
|
| Birth Weight | 1 | 2012 | 63 | 0.020 |
Why?
|
| Comorbidity | 1 | 2012 | 261 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2012 | 175 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 2070 | 0.020 |
Why?
|
| Time Factors | 1 | 2014 | 1619 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2012 | 903 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 1524 | 0.020 |
Why?
|
| Obesity | 1 | 2012 | 705 | 0.020 |
Why?
|